Google+ Facebook Twitter Twitter

Tech news: May 2022

This month's top tech news stories

Thermo Fisher Scientific

Viral transport medium

A viral transport medium enabling collection and rapid inactivation of the SARS-CoV-2 virus, which stabilises viral RNA at ambient temperature for transport and use in in vitro diagnostic testing procedures is available in Europe. Thermo Fisher Scientific developed the InhibiSURE Viral Inactivation Medium formula to be non-hazardous. Use of inactivation medium also removes the need for further inactivation steps, increasing lab throughput.

Alpha Laboratories

Sepsis detection

The BIOFIRE Blood Culture Identification 2 (BCID2) Panel rapidly detects pathogens and antimicrobial resistance genes, directly from positive blood cultures, to shorten the time to optimal therapy for sepsis.

To monitor accuracy and precision of the whole system, the new Streck MDx-Chex Control is the first-of-its-kind quality control, specifically designed to meet the standards for verifying the entire analytical process of the BioFire BCID2 sepsis assay. It is now available in the UK.


£1m innovation fund

A pathology partnership is celebrating its first anniversary with the launch of an initiative making thousands of pounds available for groundbreaking research projects.

SYNLAB’s partnership with Guy’s and St Thomas’, and King’s College Hospital NHS Foundation Trusts – known as Viapath – was formed in April last year. Twelve months on, it has unveiled the Innovation Accelerator Fund (IAF).

The £1m funding pot provides a unique support opportunity for projects that drive innovation in the pathology field, encourage scientific research and development, and develop services that benefit patients.

Image credit | iStock


Related Articles

Doctor's hands vaccinating a woman stock photo CREDIT-iStock-1444188743

A universal vaccine?

Scientists have demonstrated a new, RNA-based vaccine strategy that is effective against any strain of a virus and can be used safely even by babies and the immunocompromised.

Two Scientist Microscope images and video- istock-1363238207

Enzymes open new path to universal donor blood

The quest to develop universal donor blood has taken a decisive step forward, it is claimed.

Pseudomonas aeruginosa bacteria - CREDIT - Science-Photolibrary-f0280202

New five-year plan to combat antimicrobial resistance

The government’s national action plan will commit the UK to reducing its use of antimicrobials – such as antibiotics, antifungals and antivirals – in humans and animals, strengthen surveillance of drug-resistant infections before they emerge and incentivise industry to develop the next generation of treatments.


Sponsored: Time is of the essence in the management of sepsis

Every year, 49 million people acquire sepsis. Time is of the essence for appropriate therapy as the key driver of clinical outcomes.